Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220017611 220014564 1.6 null Curative (C) 2014-10-08 2014-10-11 BOSUTINIB 2 N 220031962 BOSUTINIB
220017612 220022105 1.41 null null 2017-08-29 2017-08-30 ATG + Busulfan + Fludarabine null null 220031971 ATG + BUSULFAN + FLUDARABINE
220017613 220022105 0 null Disease modification (D) 2017-05-31 2018-01-21 AML Int Guide ADE 8+3+5 (2) N N 220031971 ADE
220017614 220008427 1.57 95.2 Curative (C) 2014-04-28 2014-05-05 Triple / Double Intrathecal Therapy N N 220031997 TRIPLE INTRATHECAL
220017615 220008428 1.65 61.5 Curative (C) null 2016-01-02 ATG + Busulfan + Fludarabine N N 220031998 ATG + BUSULFAN + FLUDARABINE
220017616 220008430 null 46 Curative (C) 2017-09-11 2017-09-11 BOSUTINIB 2 N 220032004 BOSUTINIB
220017617 220017963 1.56 104.9 Disease modification (D) 2017-08-15 2017-08-19 Cyclophosphamide TBI Allograft null N 220032005 CYCLOPHOSPHAMIDE
220017618 220008431 1.78 84.8 Curative (C) 2017-11-08 2018-02-12 Idarubicin+Tretinoin Spanish Crse4 02 N 220032007 IDARUBICIN + TRETINOIN
220017620 220014570 null 118.5 Curative (C) 2016-07-30 2016-07-30 RUXOLITINIB 2 N 220032025 RUXOLITINIB
220017621 220008438 1.84 52.2 Curative (C) 2015-05-05 2015-06-23 Cyclophosphamide TBI Allograft N N 220032027 CYCLOPHOSPHAMIDE
220017622 220008440 1.8 86 Curative (C) 2017-08-08 2017-08-10 ATG + Busulfan + Fludarabine N N 220032029 ATG + BUSULFAN + FLUDARABINE
220017623 220008442 null 60 Curative (C) 2016-12-18 2016-12-18 Triple Intrathecal 2 N 220032039 TRIPLE INTRATHECAL
220017624 220014576 1.65 93.4 Disease modification (D) null 2017-11-18 Cyclophosphamide+Fludara+TBI Allo N N 220032041 CYCLOPHOSPHAMIDE + FLUDARABINE
220017625 220008446 1.81 75 null 2014-09-29 2014-11-27 Triple / Double Intrathecal Therapy N N 220032050 TRIPLE INTRATHECAL
220017626 220008448 1.56 70.7 Palliative (P) 2017-07-23 2017-07-23 Idarubicin+Tretinoin Spanish Crse2 N N 220032050 IDARUBICIN + TRETINOIN
220017627 220008451 1.54 62.3 Curative (C) 2015-01-27 2015-02-11 CYCLOPHOSPHAMIDE Y null 220032056 CYCLOPHOSPHAMIDE
220017628 220008452 null 68.5 Disease modification (D) null 2013-03-04 Triple Intrathecal 02 N 220032058 TRIPLE INTRATHECAL
220017630 220008456 1.64 null Disease modification (D) 2017-10-10 2017-10-10 Triple Intrathecal 02 N 220032064 TRIPLE INTRATHECAL
220017631 220008458 1.64 60.3 null 2015-01-08 2015-01-09 Idarubicin+Tretinoin Spanish Crse4 Y null 220032067 IDARUBICIN + TRETINOIN
220017632 220008458 1.86 67.8 Curative (C) 2017-06-04 2017-07-15 FLAG 02 N 220032067 FLAG
220017633 220019867 1.59 52.5 Curative (C) 2015-12-02 2015-12-09 ATG + Busulfan + Fludarabine N N 220032085 ATG + BUSULFAN + FLUDARABINE
220017634 220008462 1.71 68 null 2015-12-26 2015-12-28 Triple / Double Intrathecal Therapy N N 220032087 TRIPLE INTRATHECAL
220017635 220008465 1.66 49.8 Curative (C) 2014-12-24 2016-03-05 CYCLOPHOSPHAMIDE N N 220032105 CYCLOPHOSPHAMIDE
220017636 220014588 1.78 28.5 Curative (C) 2013-10-05 2013-10-09 FLAG 02 null 220032108 FLAG
220017637 220014590 1.68 77.6 Curative (C) 2014-01-23 2014-01-25 AML Int Guide ADE 10+3+5 (1) N N 220032113 ADE
220017638 220008481 1.25 85.7 Curative (C) 2017-09-15 2017-09-15 Methotrexate intrathecal N N 220032113 METHOTREXATE INTRATHECAL
220017639 220008483 1.67 118.5 Disease modification (D) 2014-05-15 2014-10-04 Methotrexate intrathecal N N 220032121 METHOTREXATE INTRATHECAL
220017640 220008484 1.84 60 Curative (C) null 2013-12-30 Methotrexate intrathecal N N 220032126 METHOTREXATE INTRATHECAL
220017641 220008486 1.77 99.5 Neo-adjuvant (N) 2017-01-24 2017-04-16 Idarubicin+Tretinoin Spanish Crse4 N N 220032131 IDARUBICIN + TRETINOIN
220017642 220008488 1.69 0 Curative (C) 2017-11-29 2017-11-30 BOSUTINIB N N 220032142 BOSUTINIB
220017643 220008489 1.83 90 Curative (C) 2014-03-26 2014-03-30 FLAG N N 220032147 FLAG
220017644 220014596 1.84 73.6 null 2018-01-05 2018-01-13 BOSUTINIB N N 220032149 BOSUTINIB
220017645 220008493 1.7 82 Curative (C) 2014-04-27 2014-05-10 CYCLOPHOSPHAMIDE N N 220032156 CYCLOPHOSPHAMIDE
220017647 220008500 1.72 null Curative (C) 2013-05-07 2014-06-08 Triple Intrathecal null N 220032158 TRIPLE INTRATHECAL
220017648 220008503 1.67 null Curative (C) 2013-08-27 2013-08-28 Triple / Double Intrathecal Therapy 02 N 220032159 TRIPLE INTRATHECAL
220017649 220017985 0 122 Curative (C) 2015-11-24 2015-11-24 Triple / Double Intrathecal Therapy N N 220032164 TRIPLE INTRATHECAL
220017651 220017986 1.65 13.7 Curative (C) 2014-05-16 2014-09-07 RUXOLITINIB N N 220032170 RUXOLITINIB
220017652 220008512 null 66.4 Disease modification (D) 2017-12-30 2018-01-05 AML16 DA 3+10 2 N 220032175 AML16 TRIAL
220017653 220008514 1.57 63.2 Curative (C) 2019-01-14 2019-01-23 BOSUTINIB 02 N 220032181 BOSUTINIB
220017654 220008517 1.69 83.7 null 2014-06-29 2014-07-02 RUXOLITINIB N Y 220032200 RUXOLITINIB
220017655 220008517 1.84 null Curative (C) 2016-01-16 2016-01-16 ADE 8+3+5 Y N 220032200 ADE
220017656 220008518 1.77 56 Curative (C) null 2019-02-22 BOSUTINIB N null 220032218 BOSUTINIB
220017657 220008522 0 13.4 Disease modification (D) 2015-10-02 2015-10-02 AML16 DA 3+8 2 N 220032225 AML16 TRIAL
220017658 220014611 1.03 54.6 Curative (C) 2014-06-12 2014-10-03 AML Int Guide ADE 8+3+5 (2) 2 N 220032225 ADE
220017659 220014612 null 69.9 null 2017-05-16 2017-07-28 FLAG N N 220032227 FLAG
220017660 220014612 1.66 86.8 Adjuvant (A) 2016-01-01 2016-01-01 RUXOLITINIB 02 N 220032227 RUXOLITINIB
220017661 220008527 1.57 39.2 Curative (C) 2015-10-19 2015-11-10 ATG + Busulfan + Fludarabine Y N 220032251 ATG + BUSULFAN + FLUDARABINE
220017662 220008531 1.28 null Curative (C) 2017-05-01 2017-05-01 CYCLOPHOSPHAMIDE + FLUDARABINE 02 Y 220032254 CYCLOPHOSPHAMIDE + FLUDARABINE
220017663 220008531 1.7 48.5 Curative (C) null 2014-07-04 BOSUTINIB N N 220032254 BOSUTINIB
220017665 220008537 0 67.8 Disease modification (D) 2016-11-03 2016-11-09 Cyclophosphamide TBI Allograft N N 220032262 CYCLOPHOSPHAMIDE